Search clinical trials for: Methylphenidate Hydrochloride

Total 7702 results

Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults

Healthy

United States
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults

Healthy Volunteers

United States
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate

Attention Deficit Hyperactivity Disorder

United States
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects

Healthy Volunteers

United States
Purdue Pharma LP

Terminated

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) (RE-DAX)

Attention-Deficit/Hyperactivity Disorder

United States
Novartis Pharmaceuticals

Completed

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Attention Deficit/Hyperactivity Disorder

Germany, United States, Belgium, Colombia, Denmark, Sweden
Monash Medical Centre
Monash University

Recruiting

FASST - Fetal Alcohol Spectrum Stimulant Trial (FASST)

Fetal Alcohol Spectrum Disorders

Australia
Ironshore Pharmaceuticals and Development, Inc

Completed

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

Attention Deficit Hyperactivity Disorder

United States
Ironshore Pharmaceuticals and Development, Inc

Completed

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Attention Deficit Hyperactivity Disorder

China, Mexico, Korea, Republic of
Ironshore Pharmaceuticals and Development, Inc

Not yet recruiting

Ph3 Multicenter, 3wk RDBPC Efficacy, Safety & PK Study of Evening Dosed MPH HCl ER Capsules (HLD200) in Children 4-5 Yr With ADHD

Attention Deficit Hyperactivity Disorder
Janssen Korea, Ltd., Korea

Completed

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

Attention-deficit Hyperactivity Disorder

Korea, Republic of
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.

Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
Eli Lilly and Company

Completed

Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy

Attention Deficit Hyperactivity Disorder

United States
National Institute of Mental Health (NIMH)

Withdrawn

Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder

Conduct Disorder | Attention Defict Hyperactivity Disorder
Novartis Pharmaceuticals

Completed

A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.

Attention Deficit Disorder With Hyperactivity
Novartis

Completed

Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

ADHD

Germany
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); McNeil Consumer & Specialty Pharmaceuticals...

Completed

Methylphenidate in Treating Patients With Fatigue Caused by Cancer

Fatigue | Unspecified Adult Solid Tumor, Protocol Specific

United States
McNeil Consumer & Specialty Pharmaceuticals, a...

Completed

An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity
Murdoch Childrens Research Institute

Recruiting

Methylphenidate in Childhood Apraxia of Speech

Childhood Apraxia of Speech

Australia
Medice Arzneimittel Pütter GmbH & Co KG

Completed

Methylphenidate Treatment of Cancer-Related Fatigue (EMF)

Cancer-related Fatigue

Germany
Janssen-Ortho Inc., Canada

Completed

CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults

Attention Deficit Disorder With Hyperactivity
Ironshore Pharmaceuticals and Development, Inc

Completed

Pharmacokinetics of HLD200 in Children and Adolescents With ADHD

Attention-Deficit Hyperactivity Disorder

United States
M.D. Anderson Cancer Center
Ortho-McNeil Janssen Scientific Affairs, LLC

Terminated

Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

Breast Cancer | Fatigue | Gastrointestinal Cancer

United States
Medice Arzneimittel Pütter GmbH & Co KG

Completed

Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA (QUMEA)

Attention Deficit Hyperactivity Disorder

Germany
McNeil Consumer & Specialty Pharmaceuticals, a...

Completed

A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity
McNeil Consumer & Specialty Pharmaceuticals, a...

Completed

A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder
Medice Arzneimittel Pütter GmbH & Co KG

Completed

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD (EMMA)

Attention Deficit Hyperactivity Disorder

Germany
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity
M.D. Anderson Cancer Center

Completed

Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate

Fatigue

United States
Ironshore Pharmaceuticals and Development, Inc

Completed

A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD (CEES)

Attention Deficit Hyperactivity Disorder

United States
Shire

Completed

SPD544 High Strength Bioequivalence Study

ADHD

United Kingdom
Rambam Health Care Campus

Completed

The Effect Methylphenidate Hydrochloride on Pain and Auditory Sensitivity in Healthy Subjects

Pharmacological Action (PA)

Israel
McMaster University
Purdue Pharma, Canada

Completed

A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity

Generalized Anxiety Disorder | Attention Deficit Hyperactivity Disorder | Social Anxiety Disorder | Panic Disorder | Agoraphobia

Canada
Pfizer

Withdrawn

A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD

Attention Deficit Hyperactivity Disorder
Purdue Pharma, Canada

Completed

Real World Evidence of the Efficacy and Safety of FOQUEST (reFOQus)

Attention Deficit-Hyperactivity Disorder

Canada
University of Minnesota
Children's Cancer Research Fund United States

Terminated

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

Lymphoblastic Lymphoma | Brain Tumors | Lymphoblastic Leukemia, Acute, Childhood | Lymphoblastic Leukemia | Leukemia, Lymphocytic, Acute | Leukemia, Lymphoblastic, Acute | Brain Neoplasms, Malignant | ALL, Childhood | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Lymphoblastic Leukemia, Acute | Leukemia... and other conditions

United States
University Health Network, Toronto
Sanofi

Terminated

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

Prostatic Neoplasms | Fatigue

Canada
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Depression | Quality of Life | Fatigue | Brain and Central Nervous System Tumors | Cognitive/Functional Effects

United States
Massachusetts General Hospital

Completed

Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate

Drug Binding to DAT Receptors

United States
Rhodes Pharmaceuticals, L.P.

Completed

Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting

ADHD | Attention Deficit Hyperactivity Disorder

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Methylphenidate in Treating Patients With Melanoma

Fatigue | Unspecified Adult Solid Tumor, Protocol Specific

United States, Puerto Rico, South Africa
Rhodes Pharmaceuticals, L.P.

Completed

Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD

ADHD | Attention Deficit Hyperactivity Disorder

United States
Xian-Janssen Pharmaceutical Ltd.

Completed

A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants

Attention Deficit Hyperactivity Disorder (ADHD)

China
Pfizer

Completed

Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Florida International University

Recruiting

Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom

ADHD

United States
University of Arkansas

Completed

Motivated Behavior in Adults With and Without ADHD (MOBE)

ADHD

United States
TC Erciyes University

Completed

Effects of Atx and Oros-mph on Executive Functions

Executive Dysfunction
McNeil Consumer & Specialty Pharmaceuticals, a...

Completed

Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Search clinical trials for: Methylphenidate Hydrochloride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations